This is the latest funding announcement made by the Health Resources and Services Administration’s Enhancing Maternal Health Initiative.
happy women © Xavier Lorenzo - stock.adobe.com
The U.S. Department of Health and Human Services announced today through the Health Resources and Services Administration (HRSA) more than $68 million in Ryan White HIV/AIDS funding to provide care for women and children with HIV.
This announcement was made at the latest HRSA meeting held at Morgan State University in Baltimore where community leaders, state and local health officials and grant recipients gathered to discuss maternal health mortality and disparities.
This funding will also advance the Biden-Harris Administration’s National HIV/AIDS Strategy, which aims to call attention to the important of reducing HIV infections in the United States 90% by 2030.
Today’s event marks the latest meeting in the year-long Enhancing Maternal Health Initiative program. Previous gatherings have taken place in Raleigh, North Carolina, Atlanta and Flagstaff, Arizona, to name a few.
According to the press release, the Enhancing Maternal Health Initiative program aims to:
HRSA’s Ryan White HIV/AIDS Program provides care for more than 560,000 low-income people with HIV, accounting for almost half of all HIV-positive people in the United States. In 2022, more than 142,000 women received assistance and 89.9% of those women reached viral suppression, which means they are unable to transmit the disease.
Women, especially Black women are disproportionately affected by HIV. In 2019, 54% of the women with HIV were Black.
“We know that many women with HIV continue to face barriers accessing HIV care and treatment, including stigma and lack of social support,” HRSA Administrator Carole Johnson said in a news release. “Through this funding, community-based organizations across the country will deliver lifesaving, culturally responsive HIV care to help women with HIV access the health care they need and live long, healthy lives.”
FDA Accepts NDA for Gilead's New HIV Prevention Shot
February 18th 2025Lenacapavir is a twice-yearly injectable medication designed to be used as pre-exposure prophylaxis (PrEP). The FDA is giving this drug a priority review and expects to make a decision by June 19, 2025, according to a release.
Read More
HIV + Hepatitis Institute Welcomes RFK, Talks Importance of Ending the HIV Epidemic
February 13th 2025The group released a statement today expressing that they are eager to work with Robert F. Kennedy Jr. to eradicate HIV when steps into his role as the Secretary of Health and Human Services.
Read More
Trump Administration Throws U.S. AIDS Support into Turmoil
February 6th 2025PEPFAR, the main U.S.-funded global AIDS program was given a waiver from the foreign aid freeze, but there is still uncertainty and interruptions, partly because many PEPFAR programs are implemented through USAID, which has been largely shutdown by the news administration.
Read More
RFK Jr. and HIV Denial: He Says He Is Neutral, But...
January 29th 2025In 2021 book attacking Anthony Fauci, M.D., Robert F. Kennedy Jr. casts doubt on HIV being the sole cause of AIDS and presents arguments made by "HIV deniers" that believe it is bystander in the immunosuppression that characterizes AIDS.
Read More